News

Tarsus Pharmaceuticals to Engage at Key Investor Events Soon

Tarsus Pharmaceuticals to Engage at Key Investor Events Soon

Tarsus Pharmaceuticals to Engage with Investors at Upcoming Conferences

IRVINE, Calif. — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) has exciting news for investors and stakeholders as it reveals plans to participate in several key investor conferences in the near future. These events present a golden opportunity for the team to share their latest advancements and discuss their ambitious goals in the pharmaceutical sector.

Details of Upcoming Conferences

The first of these events is the Wells Fargo 20th Annual Healthcare Conference, scheduled for Wednesday, September 3rd, at 6:30 a.m. PT / 9:30 a.m. ET. Shortly after, the company will take part in the H.C. Wainwright 27th Annual Global Investment Conference on Tuesday, September 9th, at 7:30 a.m. PT / 10:30 a.m. ET. These appearances are particularly crucial as they will allow Tarsus to share insights into their innovative pipeline aimed at addressing unmet medical needs.

Accessing Live Webcasts

For those interested in catching live webcasts of these events, Tarsus will provide access through the events section on their website. This arrangement ensures that both investors and interested parties can engage with the content and keep abreast of the latest developments. Additionally, Tarsus plans to archive replays of these presentations within 48 hours for a limited time, allowing more flexibility for viewers who might miss the live sessions.

Innovations at Tarsus Pharmaceuticals

Tarsus Pharmaceuticals is at the forefront of using proven science and innovative technology to transform healthcare, with a focal point on eye care. The company is dedicated to developing treatments that address serious health issues, particularly in the realms of ophthalmology and infectious diseases. Currently, one of its flagship products, XDEMVY (lotilaner ophthalmic solution) 0.25%, has gained FDA approval in the United States for the treatment of Demodex blepharitis, marking a significant milestone in Tarsus's commitment to enhancing patient care.

Pipeline Products in Development

In addition to XDEMVY, Tarsus is actively working on several promising candidates to widen its therapeutic offerings. TP-04 is being developed as an ophthalmic gel for potential treatment options for Ocular Rosacea, while TP-05 is an oral tablet in the pipeline intended to prevent Lyme disease. This robust pipeline reflects Tarsus's strategic focus on tackling high unmet medical needs across various health segments.

Contact Information for Media and Investors

Those who wish to reach out for more information can contact the media team at Tarsus Pharmaceuticals. Adrienne Kemp, Sr. Director of Corporate Communications, is available at (949) 922-0801 or via email at AKemp@tarsusrx.com. The investor relations inquiries can be directed towards David Nakasone, Head of Investor Relations, at (949) 620-3223 or through email at DNakasone@tarsusrx.com. These points of contact are essential for investors looking to gain insight into Tarsus's future directions and the potential impacts on their investments.

Frequently Asked Questions

What conferences will Tarsus Pharmaceuticals be attending?

Tarsus will participate in the Wells Fargo 20th Annual Healthcare Conference and the H.C. Wainwright 27th Annual Global Investment Conference.

Where can I watch the presentations from the conferences?

Live webcasts of the presentations can be accessed on the Tarsus Pharmaceuticals website, with replays also available afterward.

What is the main focus of Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals focuses on advancing treatments primarily in eye care and infectious disease prevention, addressing significant unmet medical needs.

What are Tarsus Pharmaceuticals' notable products?

One flagship product is XDEMVY, an FDA-approved treatment for Demodex blepharitis. The company is also developing TP-04 and TP-05 for other conditions.

How can I contact Tarsus Pharmaceuticals for more information?

Media inquiries can be directed to Adrienne Kemp, and investor relations inquiries can be sent to David Nakasone through their provided contact information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Freedom Debt Relief Earns Service Recognition in 2026

Updated Category News Views 143

A Service Badge Carries Weight in a Rough Business Debt settlement is not a business where a pleasant phone voice alone gets the job done. People arrive carrying unsecured balances, anxiety, and usually a fair amount of distrust. That is why CNBC Select naming Freedom Debt Relief its “Best for Customer Service” is more meaningful than the usual chest-thumping...

Continue Reading
AT&T's Dec. 8 UBS Chat Puts Stankey's Updates on Watch

Updated Category News Views 0

A Small Slot With a Big Audience A calendar entry can still matter when the man holding the microphone runs AT&T. John Stankey, AT&T chairman and chief executive, is scheduled for a fireside chat at the UBS Global Media and Communications Conference on Tuesday, Dec. 8, beginning at 8:15 a.m. Eastern time. The company says the event will be webcast live through its...

Continue Reading
Zesty Takes Kubernetes Cost Control Into GPU Territory

Updated Category News Views 73

GPU waste has become the sort of cloud bill nobody wants to explain upstairs. A company buys scarce, expensive accelerators for AI work, then discovers that real workloads do not politely consume resources in neat, permanent blocks. Demand jumps, memory needs shift, and somebody either over-allocates to avoid trouble or under-allocates and gets ugly out-of-memory...

Continue Reading
Lennar Lawsuit Puts Land-Light Claims Under a Microscope

Updated Category News Views 65

Three ugly selloffs, a murky land-bank story, and a fresh securities complaint have turned Lennar into the sort of holding that makes shareholders reread every footnote. The lawsuit is not a verdict, and the allegations remain unproven, but the timeline is nasty enough that investors in NYSE:LEN should not shrug it off as ordinary housing-cycle turbulence. The Dates...

Continue Reading
Allstate's October Cat Loss Lands at $232 Million Net

Updated Category News Views 40

October’s weather bill arrived without much poetry: $232 million in estimated catastrophe losses at Allstate. Reported on November 19, that figure falls to $184 million after tax, and it deserves a clear-eyed read rather than the usual insurance-stock theatrics. A single monthly catastrophe tally is not a verdict on the company, but it is absolutely part of the...

Continue Reading
Intel Investors Face January 12 Lead Plaintiff Deadline

Updated Category News Views 41

A Narrow Calendar Window Has Opened Intel holders have another legal deadline to put on the fridge, and this one is not a casual housekeeping item. A securities class action has been filed in the Northern District of California on behalf of investors who bought or acquired Intel shares between July 23, 2026, and October 29, 2026. The deadline to seek appointment as lead...

Continue Reading
A. O. Smith's Sustainability Scorecard Has Real Teeth

Updated Category News Views 65

Numbers finally showed up wearing work boots in A. O. Smith’s latest sustainability report. The company says it beat every one of its three environmental targets, and the gaps were not the sort of rounding-error victories corporate communications teams love to polish until they shine. For investors following NYSE:AOS, that deserves a look—not a standing ovation, but a...

Continue Reading
Cooperate Marketing Lands 318th on Deloitte Fast 500

Updated Category News Views 49

A 199% revenue jump over three years will get my attention before any shiny award logo does. Cooperate Marketing says it grew that much from 2022 through 2025, enough to place No. 318 on Deloitte's 2026 Technology Fast 500 list. For a privately held Chicago marketing-technology outfit, that is a legitimate operating milestone, not just another ribbon to pin on the company...

Continue Reading
Automotive Laminates: Small Market, Real EV Leverage

Updated Category News Views 159

Cabin trim has become a surprisingly serious battleground, and that is the whole point of this automotive laminates story. Nobody buys a vehicle because somebody bragged about a multilayer film behind the door panel. Yet the materials under the fingertips, beneath the carpet, and around the dashboard increasingly decide whether an interior feels cheap, quiet, durable, or...

Continue Reading
Shenzhen Three-Way Summit Puts Stability to the Test

Updated Category News Views 130

Three nuclear powers sharing a room in Shenzhen is the sort of headline that makes every risk desk sit upright, even when the paperwork remains thin. CGTN reports that Chinese President Xi Jinping, Russian President Vladimir Putin and U.S. President Donald Trump met on November 19, 2026, in an unprecedented trilateral summit and issued a Declaration toward Peace. That is...

Continue Reading

Top 5 Most Recently Viewed Articles

Investors Puede Unirse a la Demanda Colectiva sobre RxSight, Inc.

Updated Category News Views 234

Oportunidad para Inversionistas de RxSight, Inc. Inversionistas en RxSight, Inc. (NASDAQ: RXST) están ante una oportunidad única de unirse a una demanda colectiva en defensa de sus derechos. Recientemente, se ha producido un aumento en las preocupaciones relacionadas con las declaraciones realizadas por la compañía, que parecen haber conducido a pérdidas...

Continue Reading
Enprotech's New Field Service Office: Enhancing Equipment Support

Updated Category News Views 199

Enprotech Expands Operations with New Field Service Office Enprotech, a leading North American provider of heavy equipment repair and modernization services, is thrilled to announce the grand opening of its new Field Service Office. This new facility highlights Enprotech's commitment to operational excellence and aims to enhance customer support across various...

Continue Reading
Standard Lithium's Bold Steps Towards Sustainable Lithium Production

Updated Category News Views 183

Standard Lithium's Progress and Strategic Developments VANCOUVER, British Columbia — Standard Lithium Ltd. (TSXV: SLI) (NYSE American: SLI) (FRA: S5L), a leader in lithium development, recently shared their financial and operational updates as they wrapped up the fiscal year. With a bold vision, Standard Lithium has made impressive advancements in strengthening its...

Continue Reading
Allegations of Price-Fixing Impacting Private College Costs

Updated Category News Views 96

Allegations of Price-Fixing Impacting Private College Costs Recently, a major class-action lawsuit has come to light against 40 prestigious private colleges and universities, including renowned institutions like MIT, NYU, and Brown. This legal action contends that these schools have engaged in a conspiracy through the College Board to inflate tuition costs, potentially...

Continue Reading
Seaboard Corp Stock Plummets Amidst Market Challenges

Updated Category News Views 84

Seaboard Corporation Faces Significant Stock Decline Seaboard Corporation (SEB) has recently hit a notable milestone in its stock performance, reaching a 52-week low price of $2409.58. This dip in the stock price comes amidst a turbulent market environment, reflecting broader trends affecting the company and its operational sectors. Despite the current market challenges,...

Continue Reading